E.J. McGowan & Associates, Inc. v. Biotechnologies, Inc.

736 F. Supp. 808, 15 U.S.P.Q. 2d (BNA) 1145, 1990 WL 57162, 1990 U.S. Dist. LEXIS 5338
CourtDistrict Court, N.D. Illinois
DecidedMarch 16, 1990
Docket89 C 3946
StatusPublished
Cited by12 cases

This text of 736 F. Supp. 808 (E.J. McGowan & Associates, Inc. v. Biotechnologies, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
E.J. McGowan & Associates, Inc. v. Biotechnologies, Inc., 736 F. Supp. 808, 15 U.S.P.Q. 2d (BNA) 1145, 1990 WL 57162, 1990 U.S. Dist. LEXIS 5338 (N.D. Ill. 1990).

Opinion

ORDER

NORGLE, District Judge.

Before the court is the motion of defendants, John D. Perry and Biotechnologies, *809 Inc. (“Biotech”) to dismiss the complaint of plaintiff E.J. McGowan & Associates, Inc. (“McGowan”). For the following reasons, the court grants the motion.

Biotech is a Maine corporation with its principle place of business in Bryn Mawr, Pennsylvania. Dr. John D. Perry is a Pennsylvania resident and the President of, and partial stockholder in, Biotech. Mr. Perry owns the patent to the “Vaginal Myograph” pubococcygeus contraction monitor system, an electrical sensing device aiding in the treatment of incontinence.

McGowan is an Illinois corporation with its principle place of business in Elmhurst, Illinois. McGowan also manufactures and sells electrical sensing devices used in the treatment of incontinence. In particular, McGowan manufactures the Advanced Perineometer Model 127-002. McGowan received a letter from counsel for Biotech, dated October 13, 1988, warning that the Advanced Perineometer might infringe Dr. Perry’s patent. Counsel for McGowan responded by forwarding examples of the Advanced Perineometer to Biotech’s counsel. In a letter dated March 13, 1989, Biotech’s counsel stated that it had determined that the Advanced Perineometer did infringe Dr. Perry’s patent, and threatened possible litigation. McGowan then filed the instant suit, seeking a declaratory judgment that McGowan was not infringing Dr. Perry’s patent.

DISCUSSION

Defendants have moved to dismiss plaintiff’s complaint on the basis that this court lacks personal jurisdiction over both Dr. Perry and Biotech.

The burden to establish jurisdiction is on the party asserting it. Saylor v. Dyniewski, 836 F.2d 341, 342 (7th Cir. 1988); Integrated Business Information Service v. Dun & Bradstreet, 714 F.Supp. 296 (N.D.Ill.1989); Gordon v. Tow, 148 Ill. App.3d 275, 279-80, 101 Ill.Dec. 394, 397, 498 N.E.2d 718, 721 (1st Dist.1986). A federal district court in Illinois has personal jurisdiction over a party only if an Illinois state court could have such jurisdiction. John Walker & Sons v. DeMert & Dougherty, Inc., 821 F.2d 399, 401 (7th Cir.1987); Dun & Bradstreet, 714 F.Supp. at 299. In Illinois, a court may acquire personal jurisdiction over a non-resident defendant by showing the defendant was either “doing business” within the state or is subject to jurisdiction under the Illinois long arm statute 1 Asset Allocation & Mgt. Co. v. Western Employers Insurance Co., 892 F.2d 566, 570 (7th Cir.1989); Heil, 863 F.2d at 548. By “doing business” within the state, a corporation is deemed to have consented to jurisdiction. R.W. Sawant & Co. v. Allied Programs Corp., 111 Ill.2d 304, 312-13, 95 Ill.Dec. 496, 501, 489 N.E.2d 1360, 1365 (1986); Cook, 87 Ill.2d at 199, 57 Ill.Dec. at 734, 429 N.E.2d at 851. Although there is no all-inclusive test for “doing business” in this state, the Illinois Supreme Court has held that “the term means that the corporation is conducting business in Illinois of such a character and extent as to warrant the inference that the corporation has subjected itself to the jurisdiction and laws of the district in which it is served and in which it is bound to appear when a proper agent has been served with process”. Cook, 87 Ill.2d at 201, 57 Ill.Dec. at 735, 429 N.E.2d at 852. This conduct must not be occasional or casual but must be substantial and show a fair measure of permanence and continuity. Asset Allocation, 892 F.2d at 570; Cook, 87 Ill.2d at 202-03, 57 Ill.Dec. at 736, 429 N.E.2d at 853.

Plaintiff bases its entire jurisdictional argument on the assertion that Biotech was “doing business” in the Northern District, ignoring the Illinois long arm stat *810 ute 2 . Plaintiffs Response, p. 6. However, neither Dr. Perry nor Biotech maintain an office, a mailing address or a telephone number in Illinois. Dr. Perry, as an individual, has only been in Illinois three times, twice on vacation and once in attendance at a convention. Biotech has engaged in business in Illinois on only five occasions, three days in attendance at a convention and two days in negotiations with Hollister, Inc., an Illinois corporation. These facts do not show the “fair measure of permanence and continuity” necessary for jurisdiction under this doctrine 3 . Cook, 87 Ill.2d at 202-03, 57 Ill.Dec. at 736, 429 N.E.2d at 853; Sawant, 111 Ill.2d at 313, 95 Ill.Dec. at 501, 489 N.E.2d at 1365. Therefore, plaintiff has failed to demonstrate that defendants have consented to jurisdiction in this court under the “doing business” standard.

Although not raised by the plaintiff, jurisdiction could also be based on the Illinois long arm statute 4 . Formerly, the reach of the Illinois long arm statute was considered to be coterminous with the “minimum contacts” test of the due process clause. However, the Illinois Supreme Court, in Cook Associates, Inc. v. Lexington United Corp., 87 Ill.2d 190, 57 Ill.Dec. 730, 429 N.E.2d 847 (1981) rejected this notion 5 . See also, J. Walker, 821 F.2d at 402; Dun & Bradstreet, 714 F.Supp. at 299; Gordon, 148 Ill.App.3d at 279, 101 Ill.Dec. at 397, 498 N.E.2d at 721. Therefore, in determining whether an Illinois court could properly exercise jurisdiction, a federal court should ask three questions: (1) whether the defendant engaged in one of the jurisdictional acts enumerated by the statute; (2) whether the cause of action is one “arising from” the jurisdictional act; and (3) whether the exercise of long arm jurisdiction is consistent with due process as defined by prevailing constitutional standards. J. Walker, 821 F.2d at 402; Jacobs/Kahan & Co. v. Marsh, 740 F.2d 587, 590 (7th Cir.1984).

The first inquiry this court makes is whether Dr. Perry and Biotech engaged in one of the jurisdictional acts enumerated in the statute. The only possible jurisdictional act in this case is the transaction of business within the state. Dr. Perry’s total personal contacts with Illinois encompass three days, two spent on vacation here and one in attending a convention. Nowhere does plaintiff allege the transaction of business by Dr. Perry as an individual within the state.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Med-Tec, Inc. v. Kostich
980 F. Supp. 1315 (N.D. Iowa, 1997)
IDS Life Insurance v. SunAmerica, Inc.
958 F. Supp. 1258 (N.D. Illinois, 1997)
Haedike v. Kodiak Research, Ltd.
814 F. Supp. 679 (N.D. Illinois, 1993)
Brandt Consolidated, Inc. v. Agrimar Corp.
801 F. Supp. 164 (C.D. Illinois, 1992)
Braden Shielding Systems v. Shielding Dynamics
812 F. Supp. 819 (N.D. Illinois, 1992)
Esp, Inc. v. Eec, Ltd.
783 F. Supp. 1135 (N.D. Illinois, 1992)
Hrubec v. National Railroad Passenger Corp.
778 F. Supp. 1431 (N.D. Illinois, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
736 F. Supp. 808, 15 U.S.P.Q. 2d (BNA) 1145, 1990 WL 57162, 1990 U.S. Dist. LEXIS 5338, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ej-mcgowan-associates-inc-v-biotechnologies-inc-ilnd-1990.